Aarelab AG Report issue

For profit Phase 4
Founded: Olten Switzerland (2011)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2013
NCT01832129
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

cyanocobalamin (berocca) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Vitamin B 12 Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1